Company Overview of Relypsa, Inc.
Key Executives for Relypsa, Inc.
|John A. Orwin||134 Relationships||Chief Executive Officer, President and Director||51|
|Kristine M. Ball||No Relationships||Chief Financial Officer, Principal Accounting Officer and Senior Vice President||44|
|Lance Berman M.D., M.S||No Relationships||Chief Medical Officer and Senior Vice President||45|
|J. Scott Garland||10 Relationships||Chief Commercial Officer and Senior Vice President||47|
|Stephen D. Harrison Ph.D.||No Relationships||Chief Scientific Officer and Senior Vice President||51|
|View More Key Executives|
Relypsa, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Daniel K. Spiegelman B.A., M.B.A.||21 Relationships||BioMarin Pharmaceutical Inc.||57|
|John A. Orwin||134 Relationships||Relypsa, Inc.||51|
|Paul J. Hastings||194 Relationships||OncoMed Pharmaceuticals, Inc.||56|
|David W. J. McGirr MBA||40 Relationships||Cubist Pharmaceuticals LLC||62|
|Craig J. Hawker Ph.D.||21 Relationships||Relypsa, Inc.||--|
Relypsa, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee MBA||David W. J. McGirr||40 Relationships||3 Executives|
|Compensation Committee||Paul J. Hastings||194 Relationships||3 Executives|
|Nominating Committee B.A., M.B.A.||Daniel K. Spiegelman||21 Relationships||3 Executives|
|Corporate Governance Committee B.A., M.B.A.||Daniel K. Spiegelman||21 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$18.4M|
|Total Value of Options||$546.3K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.